BNP PARIBAS FINANCIAL MARKETS - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESW and the CUSIP is 81362J118. A total of 1 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2019$79,880,000
-10.5%
446,2560.0%0.00%
Q3 2019$89,251,000
-13.0%
446,2560.0%0.00%
Q2 2019$102,639,000
+21.1%
446,2560.0%0.00%
Q1 2019$84,789,000
-24.0%
446,2560.0%0.00%
Q4 2018$111,564,000
-62.5%
446,2560.0%0.00%
Q3 2018$297,876,000
-1.8%
446,2560.0%0.00%
-100.0%
Q2 2018$303,454,000
-16.0%
446,2560.0%0.00%0.0%
Q1 2018$361,467,000
-3.6%
446,2560.0%0.00%0.0%
Q4 2017$374,855,000446,2560.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2020
NameSharesValueWeighting ↓
&PARTNERS 21,961$5,0000.01%
Sigma Planning Corp 161,337$37,0000.00%
Glassman Wealth Services 19,954$5,0000.00%
OneDigital Investment Advisors LLC 638$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 271$00.00%
Bank of New York Mellon Corp 10,700$2,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 963,483$222,0000.00%
UBS Group AG 315$00.00%
NOMURA HOLDINGS INC 39,352$10,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders